BioSpace News Archive

BioMidwest

Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials

Kraig Biocraft Laboratories, Inc., announces that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid.

March 19, 2024
·
2 min read
LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements

LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, announced the closing on March 18, 2024 of non-brokered private placements for $6.44 million representing the first closing of the $8.0 million combined financings announced on March 7, 2024.

March 19, 2024
·
4 min read
Business

Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Tourmaline Bio, Inc. announced its financial results for the fourth quarter and year ended December 31, 2023 and outlined recent business highlights.

March 19, 2024
·
9 min read
Biotech Bay

Cytovale’s Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Cytovale® announced new data that demonstrates how its IntelliSep® test reduced cost of care and improved efficiency of sepsis care for a large U.S. academic center.

March 19, 2024
·
3 min read
Pharm Country

Brain Recordings in People Before Surgery Reveal How All Minds Plan What to Say Prior to Speaking

A new study in people undergoing surgery to treat seizures related to epilepsy shows that pauses in speech reveal information about how people’s brains plan and produce speech.

March 19, 2024
·
5 min read
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning

AstriVax is pleased to welcome Dr. Gregory Fanning as its Chief Business Officer.

March 19, 2024
·
2 min read
Drug Development

IRLAB’s Mesdopetam Displays Antipsychotic Properties in an Advanced Model of Parkinson’s Disease Psychosis

IRLAB Therapeutics AB announced that a scientific paper reporting the effects of IRLAB’s candidate drug mesdopetam in a preclinical model of Parkinson’s disease psychosis has been published in the journal Neurotherapeutics.

March 19, 2024
·
3 min read
Policy

Biovica rReceives Positive Patent Notification for Immunotherapies

Biovica International Biovica has received a positive International Preliminary Report on Patentability covering the use of TKa as a prognostic and monitoring marker in cancer treatment outside the CDK 4/6 inhibitor space, expanding the market potential for the DiviTum TKa technology by four to six times.

March 19, 2024
·
2 min read
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Therapeutics Inc. is pleased to provide a summary of Company’s achievements in 2023 and objectives planned for 2024.

March 19, 2024
·
6 min read
Drug Development

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients

Crinetics Pharmaceuticals, Inc. announced positive topline results from PATHFNDR-2, the second of two Phase 3 studies evaluating the efficacy and safety of oral, once-daily investigational paltusotine for the treatment of acromegaly.

March 19, 2024
·
10 min read